Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19

Background: The COVID-19 pandemic presents great challenges on transmission prevention, and rapid diagnosis is essential to reduce the disease spread. Various diagnostic methods are available to identify an ongoing infection by nasopharyngeal (NPH) swab sampling. However, the procedure requires hand...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang De Marinis, Anne-Katrine Pesola, Anna Söderlund Strand, Astrid Norman, Gustav Pernow, Markus Aldén, Runtao Yang, Magnus Rasmussen
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/1c8084413d17487cb3aacc7b7d39a4e6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c8084413d17487cb3aacc7b7d39a4e6
record_format dspace
spelling oai:doaj.org-article:1c8084413d17487cb3aacc7b7d39a4e62021-11-04T15:00:43ZDetection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-192000-868610.1080/20008686.2021.1993535https://doaj.org/article/1c8084413d17487cb3aacc7b7d39a4e62021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/20008686.2021.1993535https://doaj.org/toc/2000-8686Background: The COVID-19 pandemic presents great challenges on transmission prevention, and rapid diagnosis is essential to reduce the disease spread. Various diagnostic methods are available to identify an ongoing infection by nasopharyngeal (NPH) swab sampling. However, the procedure requires handling by health care professionals, and therefore limits the application in household and community settings. Objectives: In this study, we aimed to determine if the detection of SARS-CoV-2 can be performed alternatively on saliva specimens by rapid antigen test. Study Design: Saliva and NPH specimens were collected from 44 patients with confirmed COVID-19. To assess the diagnostic accuracy of point-of-care SARS-CoV-2 rapid antigen test on saliva specimens, we compared the performance of four test products. Results: RT-qPCR was performed and NPH and saliva sampling had similar Ct values, which associated with disease duration. All four antigen tests showed similar trend in detecting SARS-CoV-2 in saliva, but with variation in the ability to detect positive cases. The rapid antigen test with the best performance could detect up to 67% of the positive cases with Ct values lower than 25, and disease duration shorter than 10 days. Conclusion: Our study therefore supports saliva testing as an alternative diagnostic procedure to NPH testing, and that rapid antigen test on saliva provides a potential complement to PCR test to meet increasing screening demand.Yang De MarinisAnne-Katrine PesolaAnna Söderlund StrandAstrid NormanGustav PernowMarkus AldénRuntao YangMagnus RasmussenTaylor & Francis Grouparticlecovid-19sars-cov-2antigen testsalivaInfectious and parasitic diseasesRC109-216ENInfection Ecology & Epidemiology, Vol 11, Iss 1 (2021)
institution DOAJ
collection DOAJ
language EN
topic covid-19
sars-cov-2
antigen test
saliva
Infectious and parasitic diseases
RC109-216
spellingShingle covid-19
sars-cov-2
antigen test
saliva
Infectious and parasitic diseases
RC109-216
Yang De Marinis
Anne-Katrine Pesola
Anna Söderlund Strand
Astrid Norman
Gustav Pernow
Markus Aldén
Runtao Yang
Magnus Rasmussen
Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
description Background: The COVID-19 pandemic presents great challenges on transmission prevention, and rapid diagnosis is essential to reduce the disease spread. Various diagnostic methods are available to identify an ongoing infection by nasopharyngeal (NPH) swab sampling. However, the procedure requires handling by health care professionals, and therefore limits the application in household and community settings. Objectives: In this study, we aimed to determine if the detection of SARS-CoV-2 can be performed alternatively on saliva specimens by rapid antigen test. Study Design: Saliva and NPH specimens were collected from 44 patients with confirmed COVID-19. To assess the diagnostic accuracy of point-of-care SARS-CoV-2 rapid antigen test on saliva specimens, we compared the performance of four test products. Results: RT-qPCR was performed and NPH and saliva sampling had similar Ct values, which associated with disease duration. All four antigen tests showed similar trend in detecting SARS-CoV-2 in saliva, but with variation in the ability to detect positive cases. The rapid antigen test with the best performance could detect up to 67% of the positive cases with Ct values lower than 25, and disease duration shorter than 10 days. Conclusion: Our study therefore supports saliva testing as an alternative diagnostic procedure to NPH testing, and that rapid antigen test on saliva provides a potential complement to PCR test to meet increasing screening demand.
format article
author Yang De Marinis
Anne-Katrine Pesola
Anna Söderlund Strand
Astrid Norman
Gustav Pernow
Markus Aldén
Runtao Yang
Magnus Rasmussen
author_facet Yang De Marinis
Anne-Katrine Pesola
Anna Söderlund Strand
Astrid Norman
Gustav Pernow
Markus Aldén
Runtao Yang
Magnus Rasmussen
author_sort Yang De Marinis
title Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
title_short Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
title_full Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
title_fullStr Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
title_full_unstemmed Detection of SARS-CoV-2 by rapid antigen tests on saliva in hospitalized patients with COVID-19
title_sort detection of sars-cov-2 by rapid antigen tests on saliva in hospitalized patients with covid-19
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/1c8084413d17487cb3aacc7b7d39a4e6
work_keys_str_mv AT yangdemarinis detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT annekatrinepesola detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT annasoderlundstrand detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT astridnorman detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT gustavpernow detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT markusalden detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT runtaoyang detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
AT magnusrasmussen detectionofsarscov2byrapidantigentestsonsalivainhospitalizedpatientswithcovid19
_version_ 1718444759230447616